Detect And Visualize Lesions With Abnormal Vascularity With Mri — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for detect and visualize lesions with abnormal vascularity with mri. 27 active patents protecting 1 drugs from 0+ originators. First major cliff: 2028. Daily refresh.

1
Approved drugs
27
Active US patents
39/100
Avg vulnerability
Annual revenue covered

Originators in Detect And Visualize Lesions With Abnormal Vascularity With Mri

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating detect and visualize lesions with abnormal vascularity with mri. Each bar = one year. Y-axis scaled to peak year (13 patents).

7
28
7
39
13
40

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Elucirem
GADOPICLENOL
Guerbet 27 39 2028-09-19

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12064487 Elucirem method of use 75 2040-01-17
12064487 Elucirem method of use 75 2040-01-17
12064487 Elucirem method of use 75 2040-01-17
12064487 Elucirem method of use 75 2040-01-17
12064487 Elucirem method of use 75 2040-01-17
12064487 Elucirem method of use 75 2040-01-17
11590246 Elucirem formulation 50 2040-01-17
11590246 Elucirem formulation 50 2040-01-17
11590246 Elucirem formulation 50 2040-01-17
11590246 Elucirem formulation 50 2040-01-17

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10973934 Elucirem composition of matter 12 2039-08-06
10973934 Elucirem composition of matter 12 2039-08-06
10973934 Elucirem composition of matter 12 2039-08-06
10973934 Elucirem composition of matter 12 2039-08-06
10973934 Elucirem composition of matter 12 2039-08-06
10973934 Elucirem composition of matter 12 2039-08-06
10973934 Elucirem composition of matter 12 2039-08-06
8114863 Elucirem composition of matter 25 2028-09-19
8114863 Elucirem composition of matter 25 2028-09-19
8114863 Elucirem composition of matter 25 2028-09-19

Related